Climb Share Price

Climb Share Price

NASDAQ: CLYM | Small Cap | Healthcare
$9.45
-$0.30 (-3.13%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Climb Stock Performance

Open
$9.70
Prev. Close
$9.75
Circuit Range
N/A
Day Range
$9.40 - $9.88
Year Range
$1.64 - $18.32
Volume
12,576
Average Traded
$9.59

Climb Share Price Today

As of 19 November 2026, Climb Bio, Inc.'s share price is $9.45. The stock opened at $9.70, compared to its previous close of $9.75. During today's trading session, Climb Bio, Inc.'s share price traded between $9.40 and $9.88, with an average price of $9.64. Over the past 52 weeks, the stock has recorded a high of $18.32 and a low of $1.64. In terms of performance, Climb Bio, Inc.'s share price has declined by 13.74% over the last six months and is up 402.39% on a year-on-year basis.

Climb Share Price Chart

Line chart of the Climb price trend over the selected period. The price fell overall, ranging from 9.40 to 9.88, ending at 9.45.
$9.40$9.88
L
Show Current Price
H

Climb Stock Fundamentals & Key Indicators

Market Cap
$640.49M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.02
Revenue (TTM)
$0.00
Return On Equity (TTM)
-26.21%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
14.21%

Climb Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$17.52-$13.72-$13.50-$15.03
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A21.69%1.60%-11.33%

Climb Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$73.90-$59.85
Net Profit MarginN/AN/A
Income ChangeN/A19.01%

Climb Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets61.962.32
Current Assets105.85154.87
Total Assets167.74217.19
Non Current Liabilities0.290.38
Current Liabilities6.984.93
Total Liabilities7.275.31
Shareholders' Equity160.48211.88

Climb Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-54.36-15.56
Investing2.83-121.09
Financing-0.02130.73

About Climb

Climb Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics for patients with immune-mediated diseases. Its pipeline includes Budoprutug, an anti-CD19 monoclonal antibody being developed for B-cell mediated diseases such as primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus, and CLYM116, an anti-APRIL monoclonal antibody being developed for the treatment of IgA nephropathy.

Climb Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$10.29
$9.43
-7.91%
Oct 2026
$11.38
$10.24
-11.03%
Sep 2026
$13.29
$11.51
-23.60%
Aug 2026
$11.67
$15.06
+26.54%
Jul 2026
$12.98
$11.90
-8.77%
Jun 2026
$10.94
$13.05
+19.18%
May 2026
$8.61
$10.95
+23.45%
Apr 2026
$7.10
$8.87
+29.49%
Mar 2026
$6.79
$6.85
-4.60%
Feb 2026
$4.50
$7.18
+60.63%
Jan 2026
$4.10
$4.47
+11.75%
Dec 2025
$1.86
$4.00
+112.77%

Climb Share Price FAQs